Cas 307520-53-2,Propanamide, N-[4-bromo-1-[(2-chlorophenyl)methyl]-1,2-dihydro-2-oxo-3-pyridinyl]-2, 2-dimethyl-

307520-53-2

Post Buying Request

Basic information

Product Name: Propanamide, N-[4-bromo-1-[(2-chlorophenyl)methyl]-1,2-dihydro-2-oxo-3-pyridinyl]-2, 2-dimethyl-
Synonyms:
CAS NO:307520-53-2
Molecular Formula: C17H18BrClN2O2
Molecular Weight: 397.699
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Propanamide, N-[4-bromo-1-[(2-chlorophenyl)methyl]-1,2-dihydro-2-oxo-3-pyridinyl]-2, 2-dimethyl-(CAS DataBase Reference)
NIST Chemistry Reference: Propanamide, N-[4-bromo-1-[(2-chlorophenyl)methyl]-1,2-dihydro-2-oxo-3-pyridinyl]-2, 2-dimethyl-(307520-53-2)
EPA Substance Registry System: Propanamide, N-[4-bromo-1-[(2-chlorophenyl)methyl]-1,2-dihydro-2-oxo-3-pyridinyl]-2, 2-dimethyl-(307520-53-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 307520-53-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

307520-53-2 Suppliers

Recommended suppliers

307520-53-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 307520-53-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,0,7,5,2 and 0 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 307520-53:
(8*3)+(7*0)+(6*7)+(5*5)+(4*2)+(3*0)+(2*5)+(1*3)=112
112 % 10 = 2
So 307520-53-2 is a valid CAS Registry Number.

307520-53-2Upstream product

307520-53-2Downstream Products

307520-55-4 C₁₈H₁₅ClN₂O

307520-53-2Relevant academic research and scientific papers

Carboxylic acid derivatives that inhibit the binding of integrins to their receptors

-

Page 35, (2010/11/30)

A method for the inhibition of the binding of α4β1 integrin to its receptors, for example VCAM-1 (vascular cell adhesion molecule-1) and fibronectin; compounds that inhibit this binding; pharmaceutically active compositions comprising such compounds; and to the use of such compounds either a above, or in formulations for the control or prevention of diseases states in which α4β1 is involved.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 307520-53-2